August 15, 2024

Notable drugs include Eliquis, a blood thinner, and various diabetes drugs. It is also estimated that this negotiation can help an estimated 1 in 7 older U.S. adults who struggle to pay for their medications.

The pathway, called Transitional Coverage for Emerging Technologies (TCET), is intended to expedite Medicare coverage of new medical devices. On average, it takes about five years after a device is authorized by the Food and Drug Administration to gain national Medicare and commercial insurance coverage, according to a survey by the Stanford Byers Center for Biodesign.

As MA enrollment climbs, there is greater scrutiny on costs associated with the program and how well it's working for beneficiaries. Research largely suggests that MA plans are paid more for members than those costs would be in traditional Medicare.

The letter urges Congress to support a 12-month continuous eligibility allowance for adults enrolled in Medicaid and CHIP.

This summary highlights the potential implications of HHS's proposed rule on health IT standards, emphasizing both the goal of advancing interoperability and the concerns about its impact on innovation and regulatory expansion.